Lian­Bio re­jects Con­cen­tra bid; Tread­well cuts work­ers; As­traZeneca inks CAR-T deal

Plus news about Ipsen’s elafi­bra­nor, Har­mo­ny’s Phase II da­ta, an ac­tivist in­vestor’s let­ter to 2sev­en­ty bio, and Sanofi’s CD38 drug.

Tang’s Con­cen­tra strikes out with …

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

SIGN UP LOG IN BECOME A PREMIUM SUBSCRIBER